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Human adenovirus serotype 7 (HAdV-7) is a reemerging pathogen identified in acute respiratory disease (ARD), particularly in epidemics
affecting basic military trainee populations of otherwise healthy young adults. The genome has been sequenced and annotated (GenBank
accession no. AY594255). Comparative genomics and bioinformatics analyses of the HAdV-7 genome sequence provide insight into its
natural history and phylogenetic relationships. A putative origin of HAdV-7 from a chimpanzee host is observed. This has implications within
the current biotechnological interest of using chimpanzee adenoviruses as vectors for human gene therapy and DNA vaccine delivery. Rapid
genome sequencing and analyses of this species B1 member provide an example of exploiting accurate low-pass DNA sequencing
technology in pathogen characterization and epidemic outbreak surveillance through the identification, validation, and application of unique
pathogen genome signatures.
Published by Elsevier Inc.
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Adenoviruses infect a very broad spectrum of hosts
across the entire span of vertebrates, including fish, frog,
and corn snake (Crespo et al., 1998; Davison et al., 2000,
2003; Farkas et al., 2002; Kovacs et al., 2003). The family
Adenoviridae comprises five genera; within this family are
51 identified serotypes of human adenoviruses (HAdVs)
that are included within the genus Mastadenoviridae. These
HAdVs, in turn, are further divided into six species
(formerly subgroups or subgenera) based on differentiating
properties that include increasingly important genome
differences, as unveiled by whole genome sequencing, as0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2004.10.041
* Corresponding author. Fax: +1 703 993 8401.
E-mail address: dseto@gmu.edu (D. Seto).well as restriction enzyme digest patterns and the classical
gold standards of serum neutralization and hemagglutina-
tion-inhibition tests (Davison et al., 2003). In 1953, the first
human adenovirus (HAdV-1) was isolated from adenoid
tissue and characterized as a cytopathic agent causing
respiratory illness (Rowe et al., 1953). Its complete genome
was only recently sequenced and annotated (Lauer et al.,
2004). Within a short time, several other HAdVs were soon
isolated, characterized, and numbered sequentially. Among
these were the serotypes HAdV-4 and HAdV-7, members of
species E and B1, respectively. These serotypes are most
commonly associated with febrile respiratory disease; in
particular, acute respiratory disease (ARD) (Erdman et al.,
2002; Hierholzer, 1995).
As of the last global survey, approximately one-fifth of
all HAdV infections reported to the World Health Organ-05) 114–129
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2002; Schmitz et al., 1983). These diseases include
respiratory tract illnesses and conjunctivitis. In infants
and immunocompromised populations, HAdV-7 can cause
outbreaks of severe disease, and, in a few cases, even lead
to death (Munoz et al., 1998). Intriguingly, even within
young, active, and previously healthy adult populations,
epidemic outbreaks and associated mortality have been
recorded (Ryan et al., 2001). Three patterns of HAdV-7
respiratory disease epidemics have been recognized: (i) the
first type occurs in winter among infants (b2 years old) and
may be fatal; (ii) the second occurs in older children and is
not usually fatal; and (iii) the third occurs as ARD in
military recruits and can have high morbidity rates along
with less-common mortality (Ryan et al., 2001; Wadell et
al., 1980).
Persistent outbreaks of HAdV-related ARD among basic
military trainees led the U.S. Army to develop vaccines
against HAdV4 and HAdV7, the two primary agents of
adenoviral ARD (Chanock et al., 1966; Gaydos and
Gaydos, 1995; Top et al., 1971a, 1971b). Despite their
effectiveness, the vaccines were discontinued in 1996. This
suspension of the vaccination program resulted in a
resurgence of ARD cases to prevaccine era levels (Ryan
et al., 2000, 2001, 2002). The reemergence of HAdV as a
major causative agent for ARD has prompted the U.S.
Department of Defense to restart a HAdV vaccine develop-
ment program.
The global epidemiology of HAdV-7 genome types has
been well documented (Erdman et al., 2002; Kajon and
Wadell, 1994; Wadell and Varsanyi, 1978; Wadell et al.,
1985). Multiple HAdV-7 genome types have been
identified by restriction enzyme analyses (Wadell and
Varsanyi, 1978). Global prevalence patterns of these
HAdV-7 genome types shift over time (Erdman et al.,
2002; Wadell et al., 1985). For example, in the period
1975–1985, the HAdV-7b genome type predominated in
North America, Europe, and Australia, while the c, d, and
e variants (the dletterT in the strain designation reflects a
restriction enzyme pattern signature) were isolated in other
parts of the world (Wadell et al., 1985). In South America,
a shift in the prevalence pattern from HAdV-7c to HAdV-
7h occurred in 1986; HAdV-7h was shown to cause severe
illness and fatalities in children (Kajon and Wadell, 1994).
In the 1980s, HAdV-7d displaced HAdV-7b as the
predominant genome type (Wadell et al., 1985). In later
years, HAdV-7d spread to parts of Asia, causing epi-
demics in Japan and Korea (Erdman et al., 2002). The
HAdV-7h and HAdV-7d2 genome types were recently
detected for the first time in North America, signaling a
possible shift in the prevalent genome types in the USA
(Erdman et al., 2002). The severity and appearance of
disease may change with genome types. It is therefore
important to understand the genomics and bioinformatics
of an ARD-relevant and human disease-relevant B1-
species member.In this report, the complete and annotated genome
sequence of prototype HAdV-7p is presented (GenBank
Accession no. AY594255). It is important both as a
reference genome and a historical footnote, and serves as
a valuable and suitable reference for studying the evolution
of the various HAdV-7 genome types in the past 50 years.
These data provide an additional powerful tool in studying
the molecular patho-epidemiology of HAdV-7 and other
ARD-causing HAdVs, especially in the development,
validation, and deployment of unique pathogen genome
signatures and genome-based advanced molecular diagnos-
tics tools.
The phylogeny and evolutionary origins of human
adenoviruses have long been a subject of study and debate.
This current study also examines the evolutionary relation-
ships between HAdV-7 and a set of recently sequenced
simian adenoviruses (Roy et al., 2004). These results have
important implications in vector development for human
gene therapy and vaccine delivery as the simian adenovi-
ruses are being explored as alternative human gene therapy
vectors (Roy et al., 2004).Results and discussion
Genome sequencing with a sparsely tiled primer array
Given the complete genome sequences of related HAdVs
archived either in GenBank (including archived partial
genomic and gene sequences) or in the database of ones
newly sequenced by the U.S. Air Force, Epidemic Outbreak
Surveillance (EOS) Consortium, PCR and DNA sequencing
primers were identified and optimized for efficient and low-
cost genome sequencing of the HAdV-7 genome based on a
sparsely tiled overlap of PCR and sequencing primers. This
protocol ensures high quality of data by generating over-
lapping and complementing sequences for a minimal
redundancy of 3-fold coverage per base.
General overview of the HAdV-7p genome sequence
Interestingly, given the past and current importance of
the central role of HAdV-7 in ARD and in understanding
HAdV patho-epidemiology, there have been no whole
genome studies to date. A reference genome of this species
B1 pathogen is critical for comparative genomics with
current and epidemic field strain isolates. Genomes from
other HAdVs have been examined and archived in
GenBank: species C (serotypes 1, 2, and 5), species A
(12), species D (17), species F (40), and species B2 (11 and
35). Studies such as these are much enhanced given
reference genomes for comparative genomics, as well as
reference genes for comparative and identity analyses.
The HAdV-7 prototype strain analyzed here is also
known as the Gomen strain, isolated as a clinical specimen
from a throat washing of a military recruit with pharyngitis
Table 1
HAdV-7 genome noncoding motif annotation
Motif Function Position
CTATCT. . .TAACAT The inverted terminal
repeat
1–108
ATAATATACC DNApol-pTP binding
site
8–18
TGGAATGGTGCCAA NFI binding site 26–39
CATGTAAATGA NFIII binding site 40–50
CTGTGTGG Sp1 recognition site 72–79
TATTTA TATA box for E1A 481–486
AATAAA polyA signal for E1A 1494–1499
TATATA TATA box for E1B 1549–1554
AATGTG polyA signal for E1B 3405–3410
TAAAGT TATA box for the pIX
gene
3384–3389
AATAAA polyA signal for pIX
gene
3910–3915
AATACA polyA signal for E2B (31374–31379)c
TGATTGGCTT Inverted CAAT box
for MLP
5823–5832
GCCACGTGAC Upstream element for
MLP
5843–5851
GCCGGGGGGG MAZ binding site for
MLP
5864–5873
TATAAAA TATA box for MLP 5874–5880
GGGGGCGGACC MAZ/SP1 binding site
for MLP
5881–5891
TCACTGT Initiator element for
MLP
5903–5909
TTGTCAGTTTC DE1 for MLP 5990–6000
AACGAGGAGGATTTGA DE2a and DE2b for
MLP
6005–6020
AATAAA polyA signal for L1 13830–13835
ATTAAA polyA signal for L2 17497–17502
AATAAA polyA signal for L3 21918–21923
AATAAA polyA signal for E2A 13372–13377
TATAAA TATA box for E3 27065–27070
AATAGA polyA signal for L4 27547–27552
AATAAA polyA signal for
the E3
31128–31133
AATATC polyA signal for L5 34122–34127
AATATA polyA signal for E4 (32317–32322)c
TATATATA TATA box for E4 (35000–35005)c
ATAATATACC DNApol-pTP binding
site
(35289–35298)c
CTATCT. . .TAACAT The inverted terminal
repeat
(35199–35306)c
DNA sequence motifs are identified and located on the genome of HAdV-7.
Their nucleotide signatures and putative functions are indicated. The
nucleotide positions of their location are noted in the 5V to 3V orientation.
Functionality, which is embedded within the complementary strand, is
designated by dcT, for example, b(4089–4094)cQ.
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contemporary with the Greider strain (Rowe et al., 1958),
aka HAdV-7a, which has been studied extensively (Craw-
ford-Miksza et al., 1999; Li and Wadell, 1986). There are
genome differences between the two strains (manuscript in
preparation).
The HAdV-7p genome sequence is 35306 bp in length
and has an overall base composition of 25.36% A, 25.77%
C, 25.24% G, and 23.6% T. Its G + C content of 51.03%
is within the 50–52% range observed earlier for the HAdV-
B species (Shenk, 1996). As observed in the genomes of
other members of Mastadenoviruses, the HAdV-7 genome
is organized into early, intermediate, and late transcription
regions. A total of 48 coding sequences were identified
in this genome sequence, including seven predicted
genes.
Noncoding motifs
Table 1 presents noncoding DNA sequence motifs
uncovered in the genome. These motifs include the inverted
terminal repeats (ITRs) at either end of the genome (Dan et
al., 2001). These are 108 bp long. Sequence alignments
show the HAdV-7 ITR to be most similar to those of the B1
species (HAdV-3, 16, and 21). However, the ITRs do not
contain the canonical CATCATCAAT motif that is con-
served in other HAdVs (Stone et al., 2003). Instead,
CTATCTA immediately precedes the bcoreQ motif for
DNA replication, TATAATATACC (which differs very
slightly from bcanonicalQ AATAATATACC) that binds the
preterminal protein–DNA polymerase complex is present at
8–18 bp (Temperley and Hay, 1992). These two deviations
from the canonical sequences are also observed in the
HAdV-4p genome (Purkayastha et al., in press; Tokunaga et
al., 1982), and in genomes annotated from fellow members
of the HAdV-B1 subspecies, HAdV-3 and 21 (manuscript in
preparation).
In addition to the viral factors, DNA pol and pTP,
HAdVs also require a set of host cellular factors for efficient
replication. These transcription factor DNA binding motifs
are located in the ITR region of HAdV-7 as follows: NFIII/
Oct-1 binding site (CATGTAAATGA) at (40–50 bp) and a
Sp1 binding site (CTGTGTGG) at (72–79 bp). Additionally,
the NFI binding site (TGGAATGGTGCCAA) at 26–39 bp
was also identified.
VA RNA
The virus-associated RNA (VA RNA) species are non-
protein coding sequences that have been shown to repress
the antiviral activity of host interferons (Mathews and
Shenk, 1991). For HAdV-7, the VA RNA I (170 bp) and VA
RNA II (171 bp) coding sequences were located at 10423–
10592 and 10668–10838 bp. The HAdV-7 VA RNA I is
most similar to its counterpart in HAdV-3 with 98% identity.
Analysis of VA RNA II returned greater than 90% identicalmatches with its counterparts in serotypes HAdV-3, 16, and
21, all of which belong to human adenovirus species HAdV-
B1. No significant matches were found in the genome
sequences of the HAdV-B2 members. This is not surprising,
given that HAdV-B2 contains only one VA RNA gene
(Kidd et al., 1995). However, in HAdV-C and E species
(whose members have two VA RNA genes), no significant
regions of identity were found to the HAdV-7 VA RNA II
sequence.
Table 2
HAdV-7 genome gene coding annotation
Gene Product Location
E1A 6-kDa protein (577–648, 1250–1351)
E1A 28-kDa protein (577–1156, 1250–1455)
E1A 32-kDa protein (577–1063, 1250–1455)
E1B 19-kDa small T antigen (1603–2139)
E1B 55-kDa protein (1908–3386)
E1B hypothetical 1.2kB mRNA
protein
(3144–3386)
IX hexon associated protein IX (3481–3897)
IVA2 maturation protein IVA2 (3950–5283,
5562–5574)c
E2B DNA polymerase (5053–8421)c
Hypo. hypothetical A-106 protein (6146–6466)
Hypo. hypothetical DNA binding
protein
(7987–8427)
E2B 12.6-kDa early protein (8231–8575)c
E2B terminal protein precursor (8424–10346)c
Hypo. hypothetical 14.5-kDa protein (8550–8951)
E2B 11.3-kDa early protein (9545–9859)c
Hypo. hypothetical 9.7-kDa protein (9759–10034)
VA RNA VA RNA I 10423–10592
VA RNA VA RNA II 10668–10838
L1 55-kDa protein (10869–12026)
E2B 6.1-kDa hypothetical protein (12047–12223)c
L1 protein IIIa precursor (12051–13817)
L2 penton protein (protein III) (13905–15539)
L2 protein VII precursor (15550–16128)
L2 protein V precursor (16171–17000)
L3 protein VI precursor (17554–18306)
L3 hexon protein (18419–21232)
L3 23-kDa protease (21269–21898)
E2A DNA binding protein (21985–23538)c
L4 100-kDa hexon-assembly
associated protein
(23569–26055)
Hypo. hypothetical protein (24924–25133)c
L4 22-kDa protein (25757–26356)
L4 33-kDa protein (25757–26225,
26275–2663)
L4 protein VIII, hexon-associated
protein
(26700–27383)
E3 12.1-kDa glycoprotein (27383–27703)
E3 16. 1-kDa protein (27657–28097)
E3 19.3-kDa MHC class I
antigen-binding glycoprotein
(28082–28600)
E3 20.6-kDa protein (28630–29169)
E3 20.6-kDa protein (29182–29751)
E3 7.7-kDa protein (29766–29966)
E3 10.3-kDa protein (30083–30313)
E3 14.9-kDa protein (30285–30722)
E3 14.7-kDa protein (30715–31122)
U U protein (31141–31305)c
L5 fiber protein (31320–32297)
E4 Orf 6/7 protein (32333–32584)c
E4 33.2-kDa protein (32581–33480)c
E4 13.6-kDa protein (33383–33751)c
L5 agnoprotein (33606–34115)
E4 130 aa protein (34110–34499)c
E4 13.9-kDa protein (34541–34918)c
Forty-eight coding regions are identified within the HAdV-7 genome
sequence. The genes and their products are indicated in the columns
(hypothetical and predicted proteins are marked as bHypoQ). Nucleotide
positions of the start/stop codons and of the applicable splice sites are noted in
the 5Vto 3Vdirection. Coding sequences transcribed from the complementary
strand are designated by dcT, for example, b(30923–31090)cQ.
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Table 2 displays a complete listing of the genes found in
HAdV-7p, along with chromosomal locations and putative
functions. Genes transcribed in the complementary direction
are noted with a bcQ designation following the nucleotide
locations.
Early genes
E1A
The first transcription unit to be expressed after infection
is the E1A. This transcript encodes several E1A proteins
that have important roles as transcriptional regulators within
the host cell, modulating both viral and cellular gene
expression (Flint and Shenk, 1997). These proteins lack
sequence-specific DNA-binding activity (Zu et al., 1992).
They presumably control gene expression by interacting
with cellular elements of the transcription machinery. The
alternative splicing of a common RNA precursor, tran-
scribed from a constitutively active promoter, generates
multiple E1A products. Three putative E1A proteins of sizes
6.7, 24.6, and 28.3 kDa were identified in the HAdV-7p
genome.
E1B
Three coding sequences were identified in the E1B
region. The early 20.5-kDa protein has a high BLAST score
to the small T antigen that is conserved in other
adenoviruses. E1B 54.7-kDa protein has identity to the
large T antigen protein, which has been shown to inhibit
cellular p53-mediated host defense mechanisms (Yew et al.,
1994). This large T antigen protein also plays a role in
regulating viral late gene expression. A third coding
sequence encodes an 8.9-kDa protein with identity to the
1.26-kb mRNA product that has been identified in the
HAdV-C species.
E2
Proteins required for viral DNA replication are encoded
in the E2 transcriptional unit. These are divided into two
regions, E2A and E2B. HAdV DNA replication system has
been shown to require three viral factors: terminal protein
precursor, DNA polymerase, and DNA binding protein. A
58.2-kDa DNA binding protein was identified within E2A.
In the E2B region, a 133-kDa DNA polymerase and a 75.6-
kDa terminal protein precursor were characterized. In
addition, three hypothetical proteins of sizes 6.1, 11.3, and
12.6 kDa in the E2B region were uncovered.
E3
The E3 region of human adenoviruses encodes proteins
that counter the host immune response (Wold and Gooding,
1991). These proteins are not essential for in vitro growth.
The HAdV-7 E3 region was found to encode the 12.1-, 16.1-,
19.3-, 7.7-, 10.3-, 14.9-, and 14.7-kDa proteins. Addition-
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this transcript. The 12.1-kDa protein has significant identity
to an immunomodulating E3 protein in HAdV-2. A
glycoprotein of 16.1-kDa has homologs in other HAdV
species. The 19.3-kDa protein is a major histocompatibility
class I antigen-binding glycoprotein that prevents the lysis of
adeno-infected host cells by cytotoxic T-lymphocytes (Wold
and Gooding, 1991). Both 20.6-kDa proteins are similar to
the CR1 (conserved region 1)-containing proteins in the E3
region of other HAdVs and SAdVs (Deryckere and Burgert,
1996). The function of this 80 amino acid CR1 domain has
not been identified. The 7.7-kDa protein is reported to insert
itself into the host cell membrane; its function is yet to be
determined (Hong et al., 1988). A HAdV E3 transmembrane
protein has identity to the HAdV-7 10.3-kDa protein. This
may have a role in downregulating the epidermal growth
factor (EGF) receptor (Wold and Gooding, 1991). Both the
14.9-and 14.7-kDa proteins are similar by BLAST scores to
adenoviral E3 proteins that are known to protect virus-
infected against cells against TNF-induced cytolysis (Horton
et al., 1990).
E4
The proteins encoded by the E4 transcription unit have
various functions reported in the literature, including viral
RNA export and stabilization (Leppard, 1997). For exam-
ple, the E4 Orf6 protein combines with the E1B 55-kDa
protein to inhibit cellular p53 whereas the E4 Orf6/7 has
been shown to regulate the cellular transcription factor E2F.
The E4 Orf4 controls protein phosphorylation in infected
cells. Five putative coding sequences in the HAdV-7 E4
region were identified. These include a 13.9-kDa protein
that has identity to the adenoviral E4 protein Orf and
contains a dUTPase domain, as well as a 14.4-kDa Orf2
protein (also known as the 130 aa protein), a 13.6-kDa
nuclear binding Orf3 protein, a 14.2-kDa Orf4 protein, a
34.7-kDa Orf6 protein, and a 9.4-kDa Orf6/7 protein.
Intermediate genes
IX
As reported in the literature, the intermediate protein IX
plays a critical but poorly understood role in controlling
DNA packaging (Sargent et al., 2004). It also performs a
second function as a transcriptional activator for the major
late promoter (MLP) and other viral and cellular promoters
in HAdV-5 (Rosa-Calatrava et al., 2001). The physiological
role of protein IX as a transcriptional regulator is not clearly
understood (San Martin and Burnett, 2003; Sargent et al.,
2004). An ORF encoding a 14.1K pIX was identified at
3481–3897 bp. This coding sequence is conserved in
Mastadenviridae.
IVa2
Protein IVa2, the second intermediate protein, plays a
serotype-specific role in packaging viral DNA duringadenovirus assembly (Zhang et al., 2001). It also has a role
as a transcription factor for the major late genes (Binger and
Flint, 1984). An HAdV-7 IVa2 coding sequence was
identified at 3950–5574 bp.
Late genes
Adenoviral late genes are transcribed from the MLP.
Multiple polyA signals are utilized to produce the various
distinct mRNA species. Studies on HAdV-2 have identi-
fied essential elements of the MLP (Young, 2003). Based
on sequence comparison, all homologs of these regulatory
elements in the HAdV-7 MLP were identified. These
include the inverted CAAT box (5823–5832 bp);
Upstream element (5843–5851bp); TATA box (5874–
5880 bp); and MAZ/Sp1 binding sites flanking the TATA
box at 5864–5873 and 5881–5891 bp. The Initiator
element, which includes the transcription start site for
the MLP, is located at 5903–5909 bp. Two downstream
elements that recognize the IVa2 protein were identified at
5990–6000 bp (DE1) and 6005–6020 bp (DE2a and
DE2b). The late transcription unit encodes the major
adenoviral structural proteins and is further subdivided
into regions L1–L5, each region being expressed as a
distinct mRNA species.
L1
In the HAdV-7 L1 region, the 52-kDa protein (10869–
12026 bp) and protein IIIa (12051–13817 bp) were
identified. The 52-kDa protein is thought act as a scaffold
for capsid assembly during virus assembly (Hasson et al.,
1989). The IIIa protein is found on the outer surface of the
virus and seems to have a function in holding the virus
facets together (San Martin and Burnett, 2003). In addition,
four hypothetical L1 proteins upstream of the 52-kDa
coding sequence are contained within this transcript.
L2
Four coding sequences were identified in the L2
transcript. One of these is the penton base protein III coding
sequence. Its corresponding gene product is found at 12
virion vertices. The penton protein binds to the host
integrins via a conserved Arg–Gly–Asp (RGD) sequence
to trigger virus internalization (Wickham et al., 1993). The
HAdV-7 penton RGD motif is located at 14889–14897 bp.
These two surface proteins may contribute to the role of
HAdV-7 in infection and disease. The coding sequences for
the precursors of proteins VII and V, which are found at the
viral core, were located at 15550–16128 and 16171–17000
bp, respectively.
L3
In the L3 transcript region, three coding sequences were
located: minor capsid protein precursor pVI, hexon, and
23-kDa protease. The minor capsid protein is found on the
inner capsid surface and probably serves as a structural
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HAdV-7 genome, the coding sequence for the pVI
precursor is located at 17554–18306 bp. The coding
sequence for the 105.7-kDa HAdV-7 hexon was located
at 18419–21232 bp. The hexon protein is the major
structural component of the adenovirus capsid, making up
about 63% of the virion mass. The HAdV-7 hexon is a 937
amino acid long protein that shares 95% amino acid
identity with its homolog in HAdV-3. This appears to be a
determinant for species B1 infection (Erdman et al., 2002;
Li and Wadell, 1999). The final coding sequence in the
HAdV-7 L3 region encodes a 23-kDa protease and was
located at 21269–21898 bp. The 23-kDa protease is
required for the cleavage of viral proteins during virus
maturation and assembly.
L4
Four coding sequences were identified in the HAdV-7 L4
transcript region. These correspond to the following: 100-
kDa protein (23569–26055 bp); 22-kDa protein (25439–
25978 bp); 33-kDa protein (25757–26630 bp); and pVIII
protein (26700–27383 bp). The 100-kDa nonstructural
protein probably has a function in hexon assembly and is
required for the efficient translation of the late viral mRNAs
(Hayes et al., 1990; Oosterom-Dragon and Ginsberg, 1981).
The function of the 22-kDa protein has yet to be identified.
The 33-kDa protein is believed to play an indispensible role
in virion assembly (Finnen et al., 2001). The pVIII protein is
found on the interior surface of the capsid and is thought to
serve as a bridge between the capsid and the viral core
elements (San Martin and Burnett, 2003). Like its other
adenoviral homologs, the HAdV-7 pVIII is rich in proline,
arginine, and lysine (~12.7%), and probably has a highly
disordered structure.
L5
The L5 region of HAdV-7 encodes the 35.2-kDa fiber
protein at 31320–32297 bp. Specifically, the HAdV-7 fiber
is 325 amino acids in length. It forms a trimeric fiber
assembly that protrudes from the vertices of the icosahe-
dral adenoviral capsid. The N-terminal domain is reported
to attach noncovalently to the penton base protein, while
the globular C-terminal bknobQ domain binds host cell
receptor. This fiber is considered to be a major determinant
of tissue tropism. In some species, it binds to a cell surface
receptor, Coxsackie, and Adenovirus Receptor (CAR)
(Howitt et al., 2003). A detailed study of the crystal
structure of the HAdV-12 knob domain bound to CAR has
revealed the key fiber residues that are required for this
binding (Howitt et al., 2003). These include Asp415,
Pro417, and Pro418. Another important residue Lys429 is
conserved throughout all subtypes except for species F.
However, unlike members of the other HAdV species,
members of species B apparently do not bind this CAR
(Defer et al., 1990). CLUSTALX-based multiple sequence
alignment of the fiber sequences from the species A, B, C,and E HAdVs with the HAdV-12 fiber sequence shows
that while the Asp415 residue is present in HAdV-2, 4, and
12, it is replaced with an Asn in the HAdV-7 genome (Fig.
1). The residues Pro417 and Pro418 are replaced with Thr
and Ala, respectively, in HAdV-7. This lack of conserva-
tion of the key binding residues may explain why HAdV-7
and the other HAdV-Bs do not attach to CAR. The L5
region also encodes a putative DNA binding protein at
33606–34115 bp. A similar L5 DNA binding protein
coding sequence is found in other HAdV-Bs (unpublished
observation).
Miscellaneous proteins
Seven hypothetical proteins were identified across the
entire HAdV-7 genome sequence. Four hypothetical coding
sequences were identified in the ~5 kb stretch between the
MLP initiator element and the L1 52-kDa protein coding
sequence: (a) A-106 homolog; (b) DNA binding protein; (c)
14.7-kDa protein; and (d) 9.7-kDa protein. E2B encodes
two hypothetical proteins of sizes 11.3 and 12.6 kDa. A
7.9-kDa protein coding sequence lies between the E2 and
E4 genes; it has no apparent similarity to any other coding
sequence. A short ORF with a high BLAST score against
the bU exonQ region at position 31141–31305 bp was
found, corresponding to the E3 region and reading in the
complementary strand. The bU exonQ was originally
reported in HAdV-40 as a small coding region extending
from an initiation codon to a splice donor site and may
represent the N-terminal exon of a protein (Davison et al.,
1993). However, a downstream exon has yet to be
identified and this bU exonQ has no known function. The
hypothetical A-106 and DNA binding proteins have
homologs in HAdV-4, HAdV-1, and HAdV-11. The 14.7-
kDa protein has a homolog in HAdV-4, while both the
12.6-kDa and the U exon proteins have homologs in
HAdV-1. The presence of these hypothetical proteins
strongly suggests that the complete set of proteins encoded
by the adenoviral genome sequence has not yet been
identified and characterized.
Comparison of the HAdV B1 and B2 subspecies
The HAdV-B clade is further subdivided into subspecies
B1 and B2. The B1 subspecies members include HAdV-3,
7, 16, 21, and 50; of these, HAdV-3, 7, and 21 have been
implicated in causing respiratory disease. In contrast,
members of the B2 subspecies, HAdV-11, 14, 34, and 35,
cause urinary tract (UT) infections (with the exception of
HAdV-11a and possibly 35). Genome sequences of HAdV-
7p and 11p were compared in order to understand better the
molecular mechanisms underlying this apparent difference
in pathogenicity (Fig. 2). The whole genome sequences of
HAdV-7p and 11p were aligned with Pipmaker (http://
pipmaker.bx.psu.edu/pipmaker/), giving the result that these
two genome sequences have 4768 mismatches and 1032
Fig. 1. Multiple sequence alignment (MSA) of fiber proteins of HAdV species A, B, C, and E. The fiber protein interacts with cell receptors, for example,
Coxsackie and Adenovirus Receptor (CAR), to determine tropism. Amino acid sequences of the species B (HAdV-3 and 7), C (HAdV-2 and 5), and E (HAdV-
4) fibers are aligned with the HAdV-12 (species D) fiber sequence. The three-dimensional structure of the HAdV-12 fiber has been solved, and the key residues
involved in CAR binding have been mapped. Some of these key residues are marked by numbers at the top of the alignment to show conservation among the
CAR binding species A, C, and E adenoviruses, and relative to HAdV-12: D415 (1), P417 (2), P418 (3), and K429 (4). CLUSTALX is used for the MSA; this
software notes amino acid alignments as follows: b*Q = conserved amino acid, b.Q = either size or hydropathy is conserved, and b:Q = both size and hydropathy
are conserved.
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There are two major regions of deletion in the HAdV-11p
sequence as compared to HAdV-7p (Fig. 2). The first region
comprises three deleted segments of sizes 156, 13, and 44
bp. These three deletions, taken together, eliminate the VA
RNA II coding region. The second deletion region is 243 bp
in size and deletes the E3 7.7 kDa coding sequence
completely. Both the VA RNA II and the E3 7.7-kDa
protein play roles in countering the host immune response
system. The potential differing responses to HAdV-7 and
HAdV-11 from the host immune system may explain, in
part, their different pathologies.
The adenovirus fiber binds to host cell receptors and
may thus be a major determinant of cell tropism (Howittet al., 2003). A close examination of the amino acid
sequences of the HAdV-7p and 11p fibers revealed fewer
differences than may be anticipated in terms of their
tropisms. The fibers share an overall identity of 81%
(Fig. 3). In the knob region, the part of the fiber that
physically interacts with the cell receptor, the two
sequences are 94% identical. Of the 11 amino acids
differences in the knob region, 7 are substitutions of
similar amino acids, conserved in size and hydropathy.
Interestingly, it has been reported recently that the HAdV-
11 serotype may have arisen as a B2-like virus, possibly
HAdV-35, acquiring the fiber coding sequence from
HAdV-7 via a homologous recombination event (Stone
et al., 2003).
Fig. 2. Selected genome alignments of HAdV-7 and HAdV-11 showing mismatches and gaps. The whole genome sequences of HAdV-7 and 11 were aligned
with Pipmaker, highlighting gross genomic differences between subspecies B1 and B2. Displayed are two major deletion regions contained within HAdV-11 as
compared to HAdV-7: (A) a deletion region in HAdV-11, comprising 156-, 13-, and 44-bp deleted segments, that eliminates the VA RNA II coding sequence
and (B) a 243-bp deletion that removes the E3 7.7-kDa protein coding sequence from HAdV-11. Displayed for each alignment and located between the
nucleotide sequence lines for HAdV-7 and HAdV-11 are the identities, differences, and gaps between the two sequences. Key: bjQ denotes a perfect match
between the two nucleotides; b:Q denotes a transition; and b–b denotes a gap. Panel C shows genome maps of a syntenic region from HAdV-7 and HAdV-11.
These schematics of the nucleotide sequence are displayed with the three forward frames of translation. Nota bene, in particular, the highlighted VA RNA
coding sequences, which are located upstream of the L1 transcription unit, show that VA RNA II is missing from HAdV-11. Color scheme: green = VA RNA I
and red = VA RNA II.
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were analyzed. The two sequences were 86% identical
(Fig. 4). Two regions of variability were identified, marked
as VR A (166 aa) and VR B (34 aa). Both variable regions
map onto outer loops in the hexon structures and may
contribute to immunogenicity (Crawford-Miksza and
Schnurr, 1996; Rux et al., 2003). In the rest of the hexon
sequences, there were 17 single nucleotide polymorphisms
(SNPs). Of these, 12 were of similar amino acid
substitutions.
The lack of the VA RNA II and E3 7.7-kDa coding
sequences appears to be the most significant difference
between the genomes of HAdV-7p and 11p. HAdV-35,
another species B2 UT pathogen, lacks these two coding
sequences as well (data not shown). As stated earlier, this
may account, in part, for the difference in the pathologies
due to HAdV-7 and HAdV-11.Comparison of ARD-relevant serotypes HAdV-7 and
HAdV-4
HAdV-7 and HAdV-4 are the most prominent etiologies
of the epidemic outbreaks of ARD. This similarity prompted
interest in comparisons of their genomes. Whole genome
alignments were performed with Pipmaker (http://pipmaker.
bx.psu.edu/pipmaker/), showing that these two genome
sequences are 77% identical. There are 5350 mismatches
and 1275 gaps between the two sequences. A comparison
of the gene contents between the two genomes shows that
the HAdV-7 genome lacks the 19.4-kDa hypothetical
protein, E3 6.3-kDa protein, and 3.5-kDa hypothetical
protein, all of which are found in the HAdV-4 genome.
On the other hand, the HAdV-4 genome lacks the following
coding sequences found in HAdV-7: E2B 6.1-kDa hypo-
thetical protein; E3 7.7-kDa protein; and L5 agnoprotein.
Fig. 3. Alignment of the HAdV-7 and HAdV-11 fiber sequences. The amino acid sequences of the HAdV-7 and HAdV-11 fibers are aligned with BLASTP
(using default settings). The shaft-knob junction is marked as bF–K.Q Amino acid differences in the knob sequences between the two fibers are marked with
black triangles. In the BLASTP algorithm, the low-complexity regions in the HAdV-7 sequence (marked as bX Q) are excluded from the alignment process. A
consensus sequence, displayed in between the HAdV-7 and HAdV-11 sequence lines, highlights identical, similar, or different residues between the two
sequences. Similar residues, conserved in either size or hydropathy, are marked as b+.Q Gaps are denoted as bQ.
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suggests a role in determining cell/tissue tropism, and
perhaps, by extension, a role in viral patho-epidemiology.
From this perspective, the fiber gene sequences of HAdV-7
and HAdV-4 were compared in greater detail. HAdV-7 and
HAdV-4 fiber amino acid sequences have an overall identity
of 30%. Fiber knobs, the region that physically interacts
with the host cell receptor, had 99 mismatches (33 similar
substitutions) and 16 gaps (Fig. 5). It is noteworthy that the
fiber knob of HAdV-7 is more similar to the fiber knob of
HAdV-11, a species B2 member and a UT pathogen, than to
the fiber knob of HAdV-4 that, like HAdV-7, is a respiratory
tract pathogen and an ARD agent. The lack of overt
correlation between biology and sequence analysis suggests
that the fiber may not be a critical determinant of adenovirus
patho-epidemiology. A more comprehensive comparative
analysis of the HAdV-B1 and HAdV-B2 species points to
multiple fiber-swapping recombination events between
these two species that have very different pathologies
(manuscript in preparation). This further suggests that the
fiber may not play a primary role in determining tissue
tropism; other, as yet uncharacterized, factors may deter-
mine what tissue a serotype/species infects and the type of
disease it causes.
Comparison of HAdV-7 and SAdV-21
Previous restriction enzyme digestion patterns have
shown that HAdV-4 shares a close phylogenetic relationshipwith SAdV (Li and Wadell, 1988). Since HAdV-7 is another
major pathogen for ARD, the genomes of HAdV-7 and
chimpanzee SAdVs were compared for overall identities
and relationships. In particular, whole genome alignments of
SAdV-21 and HAdV-7, using the BLASTZ algorithm of
Pipmaker, show that these genome sequences are 85%
identical, with 4332 mismatches and 724 gaps. One major
coding difference is that the HAdV-7 genome lacks the
CR1-delta1 protein coding sequence, which is present in
SAdV-21. SAdV-21, in turn, is missing two homologs of the
HAdV-7 coding sequences: E3 7.7-kDa protein and L5
agnoprotein. The fiber amino acid sequences of HAdV-7
and SAdV-21 are 56% identical. An alignment of the fiber
knob regions contains 92 mismatches (29 similar substitu-
tions) and 5 gaps (Fig. 6). It appears though that HAdV-7
shares a close phylogenetic relationship with SAdV-21,
suggesting a possible origin of HAdV-7 from a zoonotic
event.
Comparative genomics: putative evolutionary origins
through zoonosis
Again, the genome of HAdV-E species has been shown
to have a strong phylogenetic relationship to four simian
(chimpanzee) adenoviruses: SAdV-22, 23, 24, and 25
(Purkayastha et al., in press). Data from the above
bioinformatics analysis of the HAdV-7p genome suggest a
similar close phylogenetic relationship with the outlier from
the HAdV-4 study: SAdV-21, another simian (chimpanzee)
Fig. 4. Alignment of the HAdV-7 and HAdV-11 hexon sequences. The amino acid sequences of the HAdV-7 and HAdV-11 hexons are aligned with
BLASTP (using default parameter settings). Hexon proteins presumably contribute to the immunogenicity of the virus. The two variable regions are
marked as VR A and VR B. A consensus sequence, displayed between the HAdV-7 and HAdV-11 sequences, highlights residues that are
identical, similar, or different between the two sequences. Similar residues, conserved in either size or hydropathy, are marked as b+Q. Gaps are
denoted as bQ.
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11, and 35 were chosen to represent the B species, including
both B1 and B2 subspecies; HAdV-4, the sole member, was
chosen to represent the E species; and SAdV-21, 22, 23, 24,
and 25 were included in the analysis to represent the
chimpanzee adenoviruses. As shown in Fig. 7, six repre-
sentative proteins whose coding sequences are sampled
sequentially from across the full linear genome are
displayed: E1A 32 kDa, E1B 55 kDa, L1 55 kDa, L2
penton, L3 hexon, L5 fiber, and E4 34 kDa. The amino acid
sequences of each protein set were aligned with CLUS-
TALX (default settings). Phylogenetic trees were drawn
using the neighbor-joining method (Saitou and Nei, 1987).
This phylogeny study reconfirms a close phylogenetic
relationship between the HAdV-Bs and SAdV-21. There-fore, it is likely that the HAdV-B species arose from an
interspecies transmission of a SAdV-21-like virus from
chimpanzees to humans. Given the diversity among the
species B members and the number of HAdV-7 genome
types, this transmission is probably not a recent evolutionary
event. However, it is also theoretically possible that SAdV-
21 has evolved from a HAdV-B-like virus that underwent a
human-to-chimpanzee transmission.
The emergence of new viral species from zoonotic
events has been well documented in at least two cases
(Gao et al., 1999; Hillis et al., 1968; Slattery et al., 1999).
It has been noted that two strains of HIV, for example,
HIV-1 and HIV-2, are believed to represent cross-species
infections to humans from chimpanzee (Pan troglodytes)
(HIV-1) and sooty mangabey monkey (Cercocebus torqua-
Fig. 5. Alignment of the ARD-relevant HAdV-7 and HAdV-4 fiber sequences. The amino acid sequences of the HAdV-7 and HAdV-4 fibers are aligned with
BLASTP (using default parameter settings). There are two regions of alignment: (A) C-terminal knob regions (30% identity), where the shaft-knob junction is
marked as bF–KQ, and (B) N-terminal base region, which interacts with the penton base protein (36% identity). In the BLASTP algorithm, the low-complexity
regions in the HAdV-7 sequence (marked as bX Q) are excluded from the alignment calculation. A consensus sequence, displayed in between the HAdV-7 and
HAdV-4 lines, highlights residues that are identical, similar, or different between the two sequences. Similar residues, conserved in either size or hydropathy,
are marked as b+Q. Gaps are denoted as bQ.
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Similarly, evolutionary studies on human and simian T-
cell leukemia/lymphotropic viruses (HTLV/STLV) indi-Fig. 6. Alignment of two B1 species, HAdV-7 and SAdV-21, fiber sequences. The
BLASTP (default settings). The sequences share an overall identity of 56%. The s
between the HAdV-7 and SAdV-21 sequence lines, highlights residues that are i
conserved in either size or hydropathy, are marked as b+Q. Gaps are denoted as bcate that HTLV I and II are the result of separate
interspecies transfers between simian species and humans
(Slattery et al., 1999).amino acid sequences of the HAdV-7 and SAdV-21 fibers are aligned with
haft-knob junction is marked as bF–KQ. A consensus sequence, displayed in
dentical, similar, or different between the two sequences. Similar residues,
Q.
Fig. 7. Phylogenetic analyses of selected HAdV-7 proteins spanning the genome. The amino acid sequences of six proteins from five human adenoviruses and
five simian (chimpanzee) adenoviruses are aligned using CLUSTALX using default parameters. The sequences of HAdV serotypes 3, 7, 11, and 35 are used to
represent the B species (both B1 and B2 subspecies), while the sequences of serotype 4 are chosen to represent the E species. The sequences of HAdV-40 are
used as the bout-groupQ for reference in all of the trees. These trees are constructed using software incorporating the neighbor-joining method (Saitou and Nei,
1987). The robustness of the trees is measured by bootstrapping (1000 replications). Numbers indicate bootstrap values in support of the adjacent node. (A)
Phylogenetic analyses of the E1A 32-kDa, E1B 55-kDa, and L1 55 kDa proteins sequences. (B) Phylogenetic analyses of the L3 hexon, L5 fiber, and E4 34-
kDa protein sequences.
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vector development
The evolutionary findings presented here also have far-
reaching implications, especially in the growing field of
vector construction for DNA vaccine development and
human gene therapy. The current HAdV-5-derived vectors
can cause problems in human gene therapy protocols,
including fatality (Raper et al., 2003). In general, host
preexisting immunity to HAdV is enough of a concern tostimulate the development of alternative AdV vectors to
which neutralizing antibodies would be rare in the human
population. To this end, SAdVs are being considered as
alternatives to human adenoviruses in the design of gene
and vaccine delivery vectors (Roy et al., 2004). One study
reporting lack of neutralizing antibodies against chimpanzee
AdV in human serum samples suggests vectors derived from
them will be useful as vaccine and gene therapy vectors
(Roy et al., 2004). This observation is supported by earlier
reports in the literature using serum neutralization, comple-
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night et al., 1971; Soike et al., 1969). Intriguingly, one of
these reports noted no cross-reaction of the described
chimpanzee AdV with antisera of known simian adenovirus
types (Basnight et al., 1971).
A conflicting report noted that SAdVs were neutralized
by rabbit antisera against the HAdV-4 prototype virion (Li
and Wadell, 1988). This observation is supported by others
in the literature also using serum neutralization, complement
fixation, and hemagglutination-inhibition studies to demon-
strate cross-reaction with antisera against HAdV (Hillis et
al., 1968; Rowe et al., 1958).
Clearly, there are enough discrepancies in these gold
standard clinical assays to warrant further detailed exami-
nation into the use of chimpanzee SAdV-based vectors in
place of the current HAdV-5-derived vectors for both human
gene therapy and DNA vaccine development. The bioinfor-
matics and phylogenetic analyses presented here with
HAdV-7, as well as for the genome and bioinformatics
analysis for HAdV-4 (Purkayastha et al., in press), suggest
that a stronger link may exist between HAdV and SAdV
than previously thought. These relationships of the genomes
as well as the individual proteins, including the critical
determinant outer proteins, coupled with a potential for
cross-reaction between preexisting antibodies against HAdV
and SAdV-derived vectors with the human host should give
pause and concern.
Advanced molecular diagnostics
Analysis of HAdV-7 and related genomes allows the
development, validation, and implementation of molecular-
based diagnostic assays, particularly through the identifica-
tion of unique pathogen genome signature sequences. Rapid
sequence determinations, coupled with the versatility of
these assays, allow nearly bon-the-flyQ adjustments of
probes and arrays to meet the challenge of new and
emerging naturally occurring infectious agents, such as
SARS (Ruan et al., 2003), as well as potentially troubling
BioThreat agents. The U.S. Air Force Surgeon General
Office has supported, as part of the Directorate of
Modernization, the Epidemic Outbreaks Surveillance
(EOS) program to develop and validate a Respiratory
Pathogen Microarray (RPM) assay, based on the Affymetrix
technology, in a real-world test bed.Materials and methods
Cells, virus stocks, and DNA preparation
The American Type Culture Collection (ATCC) is the
source for HAdV-7p (ATCC #VR-7). Virus stocks were
expanded in A-549 cells (ATCC #CCL-185), a human lung
tumor cell line that proved optimal in the genomic study of
HAdV-1 (Lauer et al., 2004). Viral and DNA samples wereprepared according to protocols reported earlier (Lauer et
al., 2004; Le et al., 2001).
DNA sequencing
The HAdV-7p genome was sequenced using a
bleveragedQ primer walk strategy (Lauer et al., 2004), as
primers for PCR amplification and sequencing were avail-
able from an earlier HAdV genome sequencing project and
from various HAdV-7 gene sequences archived in GenBank.
Custom primers were chosen from newly sequenced regions
if the sequences had diverged sufficiently from the reference
genome to render the original primers useless. Gaps in
sequence coverage were closed by amplifying with PCR
methodology across the gap using custom and newly
identified sequences and also by sequencing the amplicon.
Primers were designed either side of the gap using the
sequenced regions as reference (with a preference for 19
mers with a 60 8C annealing temperature). PCR was
performed using the BIOLASE DNA Polymerase Core Kit
(Bioline, Randolph, MA) and 100–200 ng of purified
adenoviral DNA as template. Fifty-microliter reactions were
used, as per manufacturer’s recommendations, and cycled 25
times at 95 8C for 30 s (s), 55 8C for 30 s, 72 8C for 60 s. PCR
reactions were carried out in a MJ Research thermocycler
(Watertown, MA). Amplicons were purified using the
QIAquickR PCR Purification Kit (QIAGEN, Valencia,
CA) and sequenced (200 ng per reaction) with the PCR
primers using the DYEnamic ET Terminator Cycle Sequenc-
ing kit (Amersham Biosciences, Piscataway, NJ) on an ABI
Prism 377 DNA Sequencer (Applied Biosystems, Foster
City, CA).
Direct sequencing of ITR ends
The 5V and 3V ends of the linear HAdV-7 genome were
determined by direct sequencing of the repurified genomic
DNA. Primers were designed from newly obtained internal
sequences (usually internal to the first Sau 3A1 recognition
site). Template DNA (0.2–1.0 Ag/reaction) was repurified by
passing through a MicroSpin G-50 column (Amersham
Biosciences) and sequenced with the PCR primers using the
DYEnamic ET Terminator Cycle Sequencing kit (Amer-
sham Biosciences) on an ABI Prism 377 DNA Sequencer
(Applied Biosystems, Inc.).
Sequence assembly and analysis: genome annotation
DNA sequences were trimmed and assembled using
Sequencher 4.1.1 (Gene Codes Corporation, Inc.; Ann
Arbor, MI). Genome features of the DNA sequence were
revealed using the Wisconsin GCG package (SeqWeb v.2).
The genome sequence of HAdV-7 was annotated by
parsing the 35306 bases into 1-kilobase (kb) nonoverlap-
ping segments, as per an algorithm developed, and applied
successfully to earlier HAdV-1 genome analyses (Lauer
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atically against the nonredundant NCBI database using the
BLASTX program of the BLAST suite sequence-alignment
software (Altschul et al., 1990). Default parameters of word
size = 3 and expectation = 10, with the BLOSUM62
substitution matrix and with gap penalties of 11 (existence)
and 1 (extension), were applied to these analyses. Low-
complexity sequences were filtered out of the queries, as per
the BLAST algorithm.
For the prediction and identification of putative genes or
previously dnot-identifiedT genes, the web-based software
tool GenomeScan was used (Yeh et al., 2001). This tool
identified putative exons from the coding sequences, where
exon–intron borders were difficult to determine, using
exon–intron identification combined with similarity
searches to a sequence database (Yeh et al., 2001). These
hypothetical proteins were also independently identified
using another gene prediction software tool GeneMark
(Besemer and Borodovsky, 1999). GeneMark is a fifth-order
Hidden Markov Method (HMM)-based gene prediction
software. During the course of this annotation, it was noted
that while GeneMark had a slightly higher accuracy than
GenomeScan, neither gene prediction tool was completely
accurate or comprehensive in generating a list of putative
genes.
To enhance annotation progress and visualization,
Artemis, a genome annotation and editor tool (Berriman
and Rutherford, 2003), was used for the annotation process.
Both the DNA sequence and the annotation of the HAdV-7p
genome are accessible from GenBank (GenBank accession
no. AY594255).
Whole genome comparisons
PipMaker (http://bio.cse.psu.edu/pipmaker) was used to
perform nucleotide dot-blot identity-based analyses of the
whole AdV genomes now available from GenBank, using
this HAdV-7p as a reference. These nucleotide comparisons
were confirmed using other similar tools, such as Wisconsin
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